Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis.
Rossi S, Furlan R, De Chiara V, Motta C, Studer V, Mori F, Musella A, Bergami A, Muzio L, Bernardi G, Battistini L, Martino G, Centonze D.
Ann Neurol. 2012 Jan;71(1):76-83. doi: 10.1002/ana.22512.
Related citations
Natalizumab may improve cognition and mood in multiple sclerosis.
Lang C, Reiss C, Mäurer M.
Eur Neurol. 2012;67(3):162-6. Epub 2012 Jan 20.
A rare 'palisading' enhancing pattern of multiple sclerosis.
Huang CF, Lo CP, Tseng CY, Chen YC.
Eur Neurol. 2012;67(3):161. Epub 2012 Jan 18. No abstract available.
The IL-7Rα pathway is quantitatively and functionally altered in CD8 T cells in multiple sclerosis.
Kreft KL, Verbraak E, Wierenga-Wolf AF, van Meurs M, Oostra BA, Laman JD, Hintzen RQ.
J Immunol. 2012 Feb 15;188(4):1874-83. Epub 2012 Jan 18.
Associations of moderate alcohol consumption with clinical and MRI measures in multiple sclerosis.
Foster M, Zivadinov R, Weinstock-Guttman B, Tamaño-Blanco M, Badgett D, Carl E, Ramanathan M.
J Neuroimmunol. 2012 Feb 29;243(1-2):61-8. Epub 2012 Jan 18.
The association of V249I and T280M fractalkine receptor haplotypes with disease course of multiple sclerosis.
Stojković L, Djurić T, Stanković A, Dinčić E, Stančić O, Veljković N, Alavantić D, Zivković M.
J Neuroimmunol. 2012 Apr;245(1-2):87-92. Epub 2012 Jan 18.
The CD4+ T-cell subset lacking expression of the CD28 costimulatory molecule is expanded and shows a higher activation state in multiple sclerosis.
Pinto-Medel MJ, García-León JA, Oliver-Martos B, López-Gómez C, Luque G, Arnáiz-Urrutia C, Orpez T, Marín-Bañasco C, Fernández O, Leyva L.
J Neuroimmunol. 2012 Feb 29;243(1-2):1-11. Epub 2012 Jan 20.
Validation of the Comprehensive International Classification of Functioning, Disability, and Health Core Set for multiple sclerosis from the perspective of physicians.
Berno S, Coenen M, Leib A, Cieza A, Kesselring J.
J Neurol. 2012 Jan 24. [Epub ahead of print]
Pulsed steroids followed by glatiramer acetate to prevent inflammatory activity after cessation of natalizumab therapy: a prospective, 6-month observational study.
Magraner MJ, Coret F, Navarré A, Boscá I, Simó M, Escutia M, Bernad A, Navarro L, Casanova B.
J Neurol. 2011 Oct;258(10):1805-11. Epub 2011 Apr 6.
Reliability and equivalence of alternate forms for the Symbol Digit Modalities Test: implications for multiple sclerosis clinical trials.
Benedict RH, Smerbeck A, Parikh R, Rodgers J, Cadavid D, Erlanger D.
Mult Scler. 2012 Jan 25. [Epub ahead of print]
Are Mycobacterium avium subsp. paratuberculosis and Epstein-Barr virus triggers of multiple sclerosis in Sardinia?
Cossu D, Masala S, Cocco E, Paccagnini D, Frau J, Marrosu MG, Sechi LA.
Mult Scler. 2012 Jan 19. [Epub ahead of print]
The impact of environmental infections (parasites) on MS activity.
Correale J, Farez MF.
Mult Scler. 2011 Oct;17(10):1162-9. Review.
Impact of rituximab on relapse rate and disability in neuromyelitis optica.
Bedi GS, Brown AD, Delgado SR, Usmani N, Lam BL, Sheremata WA.
Mult Scler. 2011 Oct;17(10):1225-30. Epub 2011 May 26.
Fingolimod for multiple sclerosis.
Pelletier D, Hafler DA.
N Engl J Med. 2012 Jan 26;366(4):339-47. Review. No abstract available.
MS pipeline flowing, but niche remains for neuroprotection.
Waters H.
Nat Med. 2011 Nov 7;17(11):1327. doi: 10.1038/nm1111-1327. No abstract available.
Vaccination against infection in patients with multiple sclerosis.
Loebermann M, Winkelmann A, Hartung HP, Hengel H, Reisinger EC, Zettl UK.
Nat Rev Neurol. 2012 Jan 24;8(3):143-51. doi: 10.1038/nrneurol.2012.8.
Error occurred: cannot get document summary
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on